This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

The First Year of Statewide Disease Surveillance

Stephen M. Ostroff, MD; John M. Kobayashi, MD, MPH; Jay H. Lewis

JAMA. 1989;262(3):355-359.

Abstract
In 1987, Washington became the first state to require that infection with Escherichia coli serotype 0157:H7 be reported. In the first year of surveillance, 93 cases were reported, yielding an annual incidence of 2.1 cases per 100 000 population. The median age of case patients was 14 years (range, 11 months to 78 years), with the highest attack rate among children younger than 5 years (6.1 cases per 100 000 population per year). Bloody diarrhea was present in 95% of reported cases, 12% of patients developed either hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura, and one patient died. Suspected secondary cases were seen in 5% of households. Fifty-six (60%) cases occurred during June through September, as did 73% of the cases of hemolyticuremic syndrome or thrombotic thrombocytopenic purpura. Cases reported during the summer months were more likely than cases reported at other times of the year to be in children younger than 10 years. Medications, including antimicrobial medications, did not influence the duration of symptoms, nor did they appear to alter the risk of developing hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura. This newly established surveillance system in Washington demonstrates that E coli 0157:H7 is an important and common cause of bloody diarrhea in the United States.

(JAMA. 1989;262:355-359)

Author Affiliations
From the Epidemiology Program Office, Division of Field Services, Centers for Disease Control, Atlanta, Ga (Dr Ostroff); and the Washington State Public Health Laboratory, Seattle, Wash (Dr Kobayashi and Mr Lewis).

Footnotes
Reprint requests to Centers for Disease Control, 1600 Clifton Rd NE, Bldg 1/5428, Mailstop C09, Atlanta, GA 30333 (Dr Ostroff).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Expression of Putative Virulence Factors of Escherichia coli O157:H7 Differs in Bovine and Human Infections
Rashid et al.
Infect. Immun. 2006;74:4142-4148.
ABSTRACT | FULL TEXT  

Relative Nephroprotection During Escherichia coli O157:H7 Infections: Association With Intravenous Volume Expansion
Ake et al.
Pediatrics 2005;115:e673-e680.
ABSTRACT | FULL TEXT  

Hemolytic Uremic Syndrome
Noris and Remuzzi
J. Am. Soc. Nephrol. 2005;16:1035-1050.
FULL TEXT  

In vitro bactericidal activity of antimicrobial agents against enterohaemorrhagic Escherichia coli
Oie et al.
J Antimicrob Chemother 2004;54:897-903.
ABSTRACT | FULL TEXT  

Production and Characterization of Protective Human Antibodies against Shiga Toxin 1
Mukherjee et al.
Infect. Immun. 2002;70:5896-5899.
ABSTRACT | FULL TEXT  

Shiga Toxin 2 Induces Macrophage-Granulocyte Colonies from Human Bone Marrow and Cord Blood Stem Cells
Chiyoda et al.
Infect. Immun. 2002;70:5316-5318.
ABSTRACT | FULL TEXT  

Risk of Hemolytic Uremic Syndrome After Antibiotic Treatment of Escherichia coli O157:H7 Enteritis: A Meta-analysis
Safdar et al.
JAMA 2002;288:996-1001.
ABSTRACT | FULL TEXT  

Antimicrobial Therapy in Patients With Escherichia coli O157:H7 Infection
Molbak et al.
JAMA 2002;288:1014-1016.
FULL TEXT  

Human Stx2-Specific Monoclonal Antibodies Prevent Systemic Complications of Escherichia coli O157:H7 Infection
Mukherjee et al.
Infect. Immun. 2002;70:612-619.
ABSTRACT | FULL TEXT  

Toxicity of Shiga Toxin 1 in the Central Nervous System of Rabbits
Fujii et al.
Infect. Immun. 2001;69:6545-6548.
ABSTRACT | FULL TEXT  

Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999
McCarthy et al.
Pediatrics 2001;108:e59-59.
ABSTRACT | FULL TEXT  

The Risk of the Hemolytic-Uremic Syndrome after Antibiotic Treatment of Escherichia coli O157:H7 Infections
Wong et al.
NEJM 2000;342:1930-1936.
ABSTRACT | FULL TEXT  

Effects of Shiga Toxin 2 on Lethality, Fetuses, Delivery, and Puerperal Behavior in Pregnant Mice
Yoshimura et al.
Infect. Immun. 2000;68:2254-2258.
ABSTRACT | FULL TEXT  

Hemolytic Uremic Syndrome Associated With Invasive Streptococcus pneumoniae Infection
Cabrera et al.
Pediatrics 1998;101:699-699.
FULL TEXT  

Predictors of Hemolytic Uremic Syndrome in Children During a Large Outbreak of Escherichia coli O157:H7 Infections
Bell et al.
Pediatrics 1997;100:e12-e12.
ABSTRACT | FULL TEXT  

Adult Hemolytic-Uremic Syndrome: A Review of 37 Cases
Melnyk et al.
Arch Intern Med 1995;155:2077-2084.
ABSTRACT  

Escherichia coli O157:H7 and the Hemolytic-Uremic Syndrome
Boyce et al.
NEJM 1995;333:364-368.
FULL TEXT  

A Multistate Outbreak of Escherichia coli O157:H7--Associated Bloody Diarrhea and Hemolytic Uremic Syndrome From Hamburgers: The Washington Experience
Bell et al.
JAMA 1994;272:1349-1353.
ABSTRACT  

Transmission of Escherichia coli 0157:H7 Infection in Minnesota Child Day-care Facilities
Belongia et al.
JAMA 1993;269:883-888.
ABSTRACT  

Epidemiology and Complications of Escherichia coli O157:H7 Infections
Cimolai
JAMA 1989;262:3408-3408.
ABSTRACT  

AN IMPORTANT CAUSE OF BLOODY DIARRHEA IN CHILDREN
JWatch General 1989;1989:4-4.
FULL TEXT